Literature DB >> 10747891

Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells.

O Cuvillier1, L Edsall, S Spiegel.   

Abstract

Exposure to anti-Fas antibody in Jurkat cells (type II cells), which are characterized by a weak caspase-8 activation at the death-inducing signaling complex (DISC), induced a biphasic increase in ceramide levels. The early generation of ceramide preceded transient activation of acidic ceramidase and subsequent production of sphingosine, followed by cytochrome c release, activation of caspases-2, -3, -6, -7, -8, and -9, Bid cleavage, and a later sustained ceramide accumulation. The caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone inhibited early increases of ceramide and sphingosine, whereas overexpression of Bcl-x(L) had no effect, and both prevented the later sustained ceramide accumulation. Exogenous sphingosine, as well as cell-permeable C(2)-ceramide, induced cytochrome c release from mitochondria in a caspase-independent fashion leading to activation of caspase-9 and executioner caspases and, surprisingly, activation of the initiator caspase-8 and processing of its substrate Bid. These effects were also completely abolished by Bcl-x(L) overexpression. Our results suggest that sphingosine might also be involved in the mitochondria-mediated pathway of Fas-induced cell death in type II cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747891     DOI: 10.1074/jbc.M000280200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  A chicken-or-egg conundrum in apoptosis: which comes first? Ceramide or PKCdelta?

Authors:  Steven Grant; Sarah Spiegel
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  Involvement of FAN in TNF-induced apoptosis.

Authors:  B Ségui; O Cuvillier; S Adam-Klages; V Garcia; S Malagarie-Cazenave; S Lévêque; S Caspar-Bauguil; J Coudert; R Salvayre; M Krönke; T Levade
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

3.  The sphingosine-1-phosphate receptor agonist FTY720 prevents the development of anti-glomerular basement membrane glomerulonephritis.

Authors:  Manshu Sui; Jin Zhou; Rujuan Xie; Xiaogang Liu; Suhong Mu; Xibei Jia; Jing Ma; Hongchi Wu
Journal:  Mol Biol Rep       Date:  2011-08-11       Impact factor: 2.316

Review 4.  Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease.

Authors:  S-K Jo; A Bajwa; A S Awad; K R Lynch; M D Okusa
Journal:  Kidney Int       Date:  2008-03-05       Impact factor: 10.612

5.  Apoptosis-inducing effect of recombinant Caspase-3 expressed by constructed eukaryotic vector on gastric cancer cell line SGC7901.

Authors:  Yuan-Gen Fu; Yao-Jun Qu; Kai-Chun Wu; Hui-Hong Zhai; Zhi-Guo Liu; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

Review 6.  Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

Authors:  Jean-Philip Truman; Mónica García-Barros; Lina M Obeid; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-12-30

7.  Induction of apoptosis by sphingoid long-chain bases in Aspergillus nidulans.

Authors:  Jijun Cheng; Tae-Sik Park; Li-Chun Chio; Anthony S Fischl; Xiang S Ye
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

Review 8.  Sphingolipids in mitochondria.

Authors:  María José Hernández-Corbacho; Mohamed F Salama; Daniel Canals; Can E Senkal; Lina M Obeid
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-09-30       Impact factor: 4.698

9.  Caspase-10-dependent cell death in Fas/CD95 signalling is not abrogated by caspase inhibitor zVAD-fmk.

Authors:  Elodie Lafont; Delphine Milhas; Justin Teissié; Nicole Therville; Nathalie Andrieu-Abadie; Thierry Levade; Hervé Benoist; Bruno Ségui
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

10.  IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis.

Authors:  Emmanuel Mas; Marie Danjoux; Virginie Garcia; Stéphane Carpentier; Bruno Ségui; Thierry Levade
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.